Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

News Conference News EuroPCR 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Yael L. Maxwell

May 20, 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

News Conference News EuroPCR 2023

QFR More Consistent Than FFR in Nonculprit Lesions After STEMI

May 24, 2023

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

News Conference News EuroPCR 2022

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

May 25, 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI ROLEX

News Conference News EuroPCR 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Michael O'Riordan

May 18, 2022

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

News Conference News EuroPCR 2019

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

June 07, 2019

Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS

News Conference News EuroPCR 2019

Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS

Michael O'Riordan

May 21, 2019

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

“Transient” STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Conference News EuroPCR 2016

Registry Data Help Shore Up the Case for Functional Assessment in ACS, Multivessel Disease

May 19, 2016

News Conference News EuroPCR 2015

PRAGUE-13 Finds No Advantage to Complete Revascularization After Primary PCI

May 19, 2015

News Conference News EuroPCR 2014

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Yael L. Maxwell

May 23, 2014

News Conference News EuroPCR 2013

RIPCORD Study: FFR Results Change Path of Patient Management

May 23, 2013

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

May 22, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.